aeras-456
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2011 (NCT01967134)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aeras-456
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01865487 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2013 | Aeras, Statens Serum Institut, University of Cape Town |
| NCT01967134 | Phase 1 | Nov 1, 2011 | Aeras, Statens Serum Institut, University of Cape Town |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aeras | Academic/Hospital | 2 | 2 | 2 | 2011 |
| Statens Serum Institut | Academic/Hospital | 2 | 0 | 2 | 2011 |
| University of Cape Town | Academic/Hospital | 2 | 0 | 2 | 2011 |
3 organizations
Page 1 / 1